Adrianos Skaros

Adrianos Skaros

Auto-generated profile, based on publicly available information

Adrianos Skaros

Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
MZMatteo Zanella
Matteo Zanella
AVAlessandro Vitriolo
Alessandro Vitriolo
AAAlejandro Andirko
Alejandro Andirko
PMPedro Tiago Martins
Pedro Tiago Martins
SSStefanie Sturm
Stefanie Sturm
GTGiuseppe Testa
Giuseppe Testa
Dissecting the BAZ1B genetic circuitry in the neural crest brings out its critical role in shaping the modern human face.

1 December 2023 in Science Advances
Verified
Journal Article
Open access
ALAlejandro López-Tobón
Alejandro López-Tobón
RSReinald Shyti
Reinald Shyti
CVCarlo Emanuele Villa
Carlo Emanuele Villa
CCCristina Cheroni
Cristina Cheroni
PFPatricio Fuentes-Bravo
Patricio Fuentes-Bravo
GTGiuseppe Testa
Giuseppe Testa
Copy number variations at 7q11.23 cause neurodevelopmental disorders with shared and opposite manifestations. Deletion causes Williams-Beuren syndrome featuring hypersociability, while duplication causes 7q11.23 microduplication syndrome (7Dup), frequently exhibiting autism spectrum disorder (ASD). Converging evidence indicates GTF2I as key mediator of the cognitive-behavioral phenotypes, yet its role in cortical development and behavioral hallmarks remains largely unknown. We integrated proteomic and transcriptomic profiling of patient-derived cortical organoids, including longitudinally at single-cell resolution, to dissect 7q11.23 dosage–dependent and GTF2I -specific disease mechanisms. We observed dosage-dependent impaired dynamics of neural progenitor proliferation, transcriptional imbalances, and highly specific alterations in neuronal output, leading to precocious excitatory neuron production in 7Dup, which was rescued by restoring physiological GTF2I levels. Transgenic mice with Gtf2i duplication recapitulated progenitor proliferation and neuronal differentiation defects alongside ASD-like behaviors. Consistently, inhibition of lysine demethylase 1 (LSD1), a GTF2I effector, was sufficient to rescue ASD-like phenotypes in transgenic mice, establishing GTF2I -LSD1 axis as a molecular pathway amenable to therapeutic intervention in ASD.

1 May 2025 in bioRxiv
Verified
Preprint
Open access
ASAdrianos Skaros
Adrianos Skaros
AVAlessandro Vitriolo
Alessandro Vitriolo
OLOliviero Leonardi
Oliviero Leonardi
VFVeronica Finazzi
Veronica Finazzi
MPMarlene F. Pereira
Marlene F. Pereira
GTGiuseppe Testa
Giuseppe Testa
Comparative genomic studies between contemporary and extinct hominins revealed key evolutionary modifications, but their number has hampered a system level investigation of their combined roles in scaffolding modern traits. Through multi-layered integration we selected 15 genes carrying nearly fixed sapiens -specific protein-coding mutations and developed a scalable design of combinatorial CRISPR-Cas9 bidirectional perturbations to uncover their regulatory hierarchy in cortical brain organoids. Interrogating the effects of overexpression and downregulation for all gene pairs in all possible combinations, we defined their impact on transcription and differentiation and reconstructed their regulatory architecture. We uncovered marked cell type-specific effects, including the promotion of alternative fates and the emergence of interneuron populations, alongside a core subnetwork comprising KIF15 , NOVA1 , RB1CC1 and SPAG5 acting as central regulator across cortical cell types.